Laboratory News Brief - November 2020

November 18, 2020 By: Quadax

Industry-Brief-Header2

Keeping you in the know on the constantly changing world of medical billing and reimbursement, Quadax compiles industry news and articles covering important revenue cycle topics impacting the lab industry. 

 

Not already a subscriber? Enter your email here to receive industry news, insights, and updates right to your inbox.

 

Icon-Virus

 

Coronavirus (COVID-19)

 

Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases
Dark Daily

Critical shortages in medical laboratory workers and supplies are yet to be offset by new applicants and improved supply chains. But how can lab managers find, attract, and retain them?
[Read more]

Medicare beneficiaries can get monoclonal antibody COVID-19 treatments at no cost
Health IT Analytics

Medicare beneficiaries won't have to pay out-of-pocket for monoclonal antibody treatments of COVID-19 for the duration of the public health emergency
[Read more]

COVID-19 Testing: Where Do We Stand?
MedPage Today

The nation's testing program was and continues to be plagued by delays and accuracy problems, rendering its current form practically useless for controlling the virus, experts say. Pathologists and lab experts detailed the biggest challenges and the possible path ahead for testing in the U.S.
[Read more]

CMS Details Medicare Payment for New COVID-19 Antibody Drug
RevCycleIntelligence

CMS announced that Medicare payment will be available for both the purchase and administration of bamlanivimab, which can be used to treat mild-to-moderate COVID-19 in certain adult and pediatric patients, according to the FDA’s recent emergency use authorization.
[Read more]

Cancer clinical trial enrollment has plummeted. Will patients come back amid Covid-19?
STAT News

Cancer clinical trials have seen a drastic drop in patient enrollment since the onset of the Covid-19 pandemic, driven in part by some institutions pausing recruitment in order to prevent the spread of the virus. Bringing enrollment numbers back up safely will prove crucial for researchers running clinical trials and the drug companies that sponsor them.
[Read more] (subscription required)

Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation
U.S. Food and Drug Administration

The U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for SARS-CoV-2 test developers. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2. Registration is not necessary. 
[Read more]

 

Icon-DNA

 

Genomics

Team Finds Way to Protect Genetic Privacy in Research
Laboratory Equipment

In a new report, a team of Yale scientists has developed a way to protect people's private genetic information while preserving the benefits of a free exchange of functional genomics data between researchers.
[Read more]


Icon - Financial Obligations

 

 

 

 

 

 

Icon-Microscope

 

Medicare

CAP Members Call on Congress to Stop Medicare Cuts
College of American Pathologists

To preserve patient access to laboratory care and mitigate financial distress due to the pandemic, the CAP and its members strongly oppose Medicare cuts to payments for pathologists set to begin on January 1 and have activated its grassroots advocacy program to discuss the issue with members of Congress.
[Read more]


Other

Market for LDTs Expected to Top $17 Billion by 2025
G2 Intelligence

Even as the battle over FDA regulatory control over laboratory developed tests (LDTs) intensifies, the economic stakes get bigger. The current market value for LDTs is $12 billion. But a new report from a leading diagnostics industry analyst estimates that figure to grow to nearly $17.7 billion by 2025.
[Read more]

 

 

Share with your network

   

Recent Posts

Subscribe to Email Updates